Celgene Corp. (CELG)

Income Statement
Quarterly Data

Difficulty: Beginner

The income statement presents information on the financial results of a company’s business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Celgene Corp., Consolidated Income Statement (quarterly data)

USD $ in millions

	3 months ended	Mar 31, 2019		Dec 31, 2018		Sep 30, 2018		Jun 30, 2018		Mar 31, 2018		Dec 31, 2017		Sep 30, 2017		Jun 30, 2017		Mar 31, 2017		Dec 31, 2016		Sep 30, 2016		Jun 30, 2016		Mar 31, 2016		Dec 31, 2015		Sep 30, 2015		Jun 30, 2015		Mar 31, 2015		Dec 31, 2014		Sep 30, 2014		Jun 30, 2014		Mar 31, 2014
	Net product sales
	Cost of goods sold, excluding amortization of acquired intangible assets
	Gross profit
	Other revenue
	Research and development
	Selling, general and administrative
	Amortization of acquired intangible assets
	Acquisition/integration related income (charges) and restructuring, net
	Operating income
	Interest and investment income, net
	Interest expense
	Other income (expense), net
	Other income and (expense)
	Income (loss) before income taxes
	Income tax provision
	Net income (loss)

Item	Description	The company
Net product sales	Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.	Celgene Corp.’s net product sales increased from Q3 2018 to Q4 2018 but then slightly declined from Q4 2018 to Q1 2019.
Operating income	The net result for the period of deducting operating expenses from operating revenues.	Celgene Corp.’s operating income increased from Q3 2018 to Q4 2018 but then slightly declined from Q4 2018 to Q1 2019 not reaching Q3 2018 level.
Income (loss) before income taxes	Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.	Celgene Corp.’s income (loss) before income taxes declined from Q3 2018 to Q4 2018 but then increased from Q4 2018 to Q1 2019 exceeding Q3 2018 level.
Net income (loss)	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Celgene Corp.’s net income (loss) declined from Q3 2018 to Q4 2018 but then increased from Q4 2018 to Q1 2019 exceeding Q3 2018 level.

	Celgene Corp.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

Celgene Corp. (CELG)

Income StatementQuarterly Data

Income Statement
Quarterly Data